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T cell activation in lymphoid tissue occurs through interactions with cognate
peptide-major histocompatibility complex (pMHC)-presenting dendritic cells (DCs).
Intravital imaging studies using ex vivo peptide-pulsed DCs have uncovered that cognate
pMHC levels imprint a wide range of dynamic contacts between these two cell types. T
cell—DC interactions vary between transient, “kinapse-like” contacts at low to moderate
pMHC levels to immediate “synapse-like” arrest at DCs displaying high pMHC levels. To
date, it remains unclear whether this pattern is recapitulated when the immune system
faces a replicative agent, such as a virus, at low and high inoculum. Here, we locally
administered low and high inoculum of lymphocytic choriomeningitis virus (LCMV) in
mice to follow activation parameters of Ag-specific CD4+ and CD8+ T cells in draining
lymph nodes (LNs) during the first 72 h post infection. We correlated these data with
kinapse- and synapse-like motility patterns of Ag-specific T cells obtained by intravital
imaging of draining LNs. Our data show that initial viral inoculum controls immediate
synapse-like T cell arrest vs. continuous kinapse-like motility. This remains the case when
the viral inoculum and thus the inflammatory microenvironment in draining LNs remains
identical but cognate pMHC levels vary. Our data imply that the Ag-processing capacity of
draining LNs is equipped to rapidly present high levels of cognate pMHC when antigenic
material is abundant. Our findings further suggest that widespread T cell arrest during
the first 72 h of an antimicrobial immune responses is not required to trigger proliferation.
In sum, T cells adapt their scanning behavior according to available antigen levels during
viral infections, with dynamic changes in motility occurring before detectable expression
of early activation markers.
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INTRODUCTION
Naive T cells scan membranes of Ag-presenting cells (APCs), mostly dendritic cells (DCs), for
the presence of cognate peptide-loaded major histocompatibility complexes (pMHC) in lymph
nodes (LNs) and other secondary lymphoid organs. How they accomplish their search has been
well-studied in mouse LNs using intravital two-photon microscopy (2PM). This approach has
revealed that T cells move with high speeds of 12–15 µm/min on a 3D scaffold formed by
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fibroblastic reticular cells inside the T cell zone, onto which
DCs are attached (1–3). Dynamic motility parameters change
during inflammation, as T cell speeds and directionality decline
owing to cognate interactions with activated DCs. To dissect
the influence of pMHC levels on T cell motility patterns, ex
vivo activated DCs were pulsed with defined levels of cognate
peptide prior to injection into recipient mice, while T cell dwell
times were controlled by a short homing window. This approach
identified a multistep model of T cell activation, according
to which T cells dynamically respond to pMHC levels (4–
8). When intermediate levels of cognate pMHC are presented
on activated DCs, motile T cells scan DCs for a period of
a few h (phase 1; 0–8 h post LN entry). Importantly, these
transient interactions, termed kinapses, between cognate pMHC-
presenting DCs and motile T cells suffice for biochemical signal
integration mediated by Ca-flux, nuclear NFAT translocation,
c-fos phosphorylation, and CD69 upregulation (9–12). When
signals accumulate above a threshold, T cells arrest for long-term
interactions with individual DCs (phase 2; 8–20 h). During this
period, T cells presumably form an immunological synapse as
observed in in vitro studies (13). After ∼20 h, activated T cells
detach and resume motility before starting cell division (phase 3)
(14, 15). Subsequent studies have refined the 3-phase concept by
showing that pulsing DCs with high amounts of peptide induces
immediate arrest, i.e., instantaneous phase 2 induction (5, 7, 8).
In contrast, T cells may skip phase 2, i.e., stable interactions, with
DCs at very low antigen dose, yet still expand during the effector
phase (6). It is now widely recognized that changes in dynamic
T cell motility parameters closely correlate with interactions with
APCs at specific time points, and T cell speeds have been used as
surrogate marker to define kinapses and synapses in vivo without
visualizing DCs (16).
In contrast to ex vivo peptide-pulsed DC, the impact of
cognate pMHC levels on dynamic T cell behavior during
antimicrobial immune responses has thus far not been
systematically explored. It remains unclear whether the
endogenous Ag-presenting capacity suffices to induce abrupt
T cell arrest on DCs within < 24 h p.i. as observed with ex
vivo peptide-pulsed DCs, where the need for Ag processing
is bypassed. In addition, ex vivo pulsing is often performed
with saturating peptide doses leading to occupancy of virtually
all available MHC on DC surfaces, whereas physiological
infections may only lead to a fraction of pMHC pulsed with the
same cognate peptide. In such a scenario, pMHC-dependent
immediate arrest of recent T cell immigrants into reactive
LNs may not occur during microbial infections. On the other
hand, virus infections are characterized by rapid replication and
generation of high antigen levels, potentially leading to high
pMHC levels. Conceivably, this may result in similar antigen
presentation dynamics in draining LNs irrespective of initial viral
inoculum. In addition, the initial viral load may imprint distinct
interaction dynamics between T cells and DCs through Ag
level-unrelated changes in the inflammatory microenvironment,
e.g., through altered cytokine secretion.
Here, we addressed how varying initial inoculum of
lymphocytic choriomeningitis virus (LCMV) imprinted
activation marker expression in Ag-specific CD4+ and CD8+
T cells in draining LNs. We correlated these data with T cell
motility patterns using 2PM of reactive LNs, defining “synapse-
like” behavior as indirect correlate for prolonged contacts
with APCs. Our findings uncover that the antigen-presenting
machinery is readily capable of rapid and prolonged processing
of a wide range of pathogen-derived proteins for presentation
on MHC. Furthermore, we find that the initial viral inoculum
imprints dynamic T cell behavior during microbial infections
through generation of cognate pMHC, rather than other factors.
Finally, our data suggest that subtle alterations of Ag-specific
T cell migration parameters precede detectable expression of
early activation markers, making changes in motility the most
sensitive early sign of a burgeoning T cell response.
RESULTS
CD4+ and CD8+ T Cell Activation and
Proliferation Kinetics Correlate With LCMV
Inoculum
To examine the impact of virus inoculum on T cell responses, we
transferred fluorescently labeled LCMV gp33–41 peptide-specific
P14 TCR tg CD8+ T cells (“P14”) and LCMV gp61-80 peptide-
specific SMARTA TCR tg CD4+ T cells (“SMARTA”) together
with a polyclonal T cell population (“Control”) into C57BL/6
mice. One day post transfer, we infected recipient mice with a low
(1–10 × 102 pfu; low dose, LD) or high (7 × 105 pfu; high dose,
HD) inoculum of LCMV clone 13 via s.c. foot hock injection.
At 24, 48, and 72 h p.i., we isolated footpad-draining popliteal
and non-draining brachial LNs for flow cytometry (Figure 1A).
Our analysis of draining LNs after LD LCMV infection showed
a significant increase in both percentage of CD69+ and level of
CD69 expression (MFI) in P14 and SMARTA T cells starting
at 48 h p.i. (Figure 1B). At 72 h p.i., 55–67% of Ag-specific T
cells displayed detectable surface levels of CD69 (Figure 1C).
Similarly, CD25 surface markers gradually increased at 72 h after
LD LCMV infection in P14 and, more pronounced, in SMARTA
cells, whereas control CD4+ and CD8+ T cells did not increase
surface CD25 levels (Figures 1D,E). At 72 h p.i., no proliferation
of transferred P14 or SMARTA had occurred. In turn, 3–4
generations of proliferated T cells were detected at 120 h post LD
infection (Figure 1F). Thus, moderate expression of activation
markers in the first 72 h p.i. after LD LCMV infection correlated
with T cell proliferation in the following 48 h.
We examined activation marker expression and proliferation
in the HD LCMV infection model. We observed a rapid
increase in percentage of CD69+ P14 and SMARTA T cells
(88 and 89%, respectively) as early as 24 h p.i., with MFI
values peaking between 24 and 48 h before decreasing at 72 h
p.i. (Figures 1G,H). Control CD4+ and CD8+ T cells also
increased CD69 expression on the cell surface but to lower
levels as compared to Ag-specific P14 and SMARTA T cells
(Figures 1G,H). CD25 expression rapidly increased in P14 and,
more pronounced, SMARTA T cells as soon as 24 h p.i. and
peaked at 48 h p.i. (52 and 83% CD25+ P14 and SMARTA T
cells, respectively; Figures 1I,J). In contrast, CD25 expression
remained undetectable in control T cells (Figures 1I,J). In
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FIGURE 1 | CD4+ and CD8+ T cell activation and proliferation kinetics correlate with LCMV inoculum. (A) Experimental layout. Activation of control T cells, P14, and
SMARTA T cells was analyzed by flow cytometry at 24, 48, and 72 h post LD and HD LCMV infection. (B) CD69 expression on control (black), P14 (green), and
SMARTA T cells (blue) at 24 (dotted line), 48 (dashed line), and 72 h (continuous line) post LD LCMV infection. (C) Percentage and MFI of CD69+ control (gray) and
P14 (green) or SMARTA T cells (blue) post LD LCMV infection. (D) CD25 expression on control (black), P14 (green), and SMARTA T cells (blue) at 24 (dotted line), 48
(dashed line), and 72 h (continuous line) post LD LCMV infection. (E) Percentage and MFI of CD25+ control (gray) and P14 (green) or SMARTA T cells (blue) post LD
(Continued)
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FIGURE 1 | LCMV infection. (F) Flow cytometry histograms of P14 (green) and SMARTA T cells (blue) at 72 and 120 h post LD LCMV infection. (G) CD69 expression
on control (black), P14 (green), and SMARTA T cells (blue) at 24 (dotted line), 48 (dashed line), and 72 h (continuous line) post HD LCMV infection. (H) Percentage and
MFI of CD69+ control (gray) and P14 (green) or SMARTA T cells (blue) post HD LCMV infection. (I) CD25 expression on control (black), P14 (green), and SMARTA T
cells (blue) at 24 (dotted line), 48 (dashed line), and 72 h (continuous line) post HD LCMV infection. (J) Percentage and MFI of CD25+ control (gray) and P14 (green) or
SMARTA T cells (blue) post HD LCMV infection. (K) Flow cytometry histograms of P14 (green) and SMARTA T cells (blue) at 72 h post HD LCMV infection. Each dot
represents data from one mouse. Red lines depict median. Data are pooled from three independent experiments with a total of four to six mice per condition and time
point. Statistical significance was analyzed using one-way ANOVA test. *p < 0.05; **p < 0.01; ***p < 0.001.
line with these data, both P14 and SMARTA T cells had
undergone effective proliferation at 72 h post HD LCMV
infection (Figure 1K). In contrast, we did not detect a major
increase in activation markers on P14 and SMARTA T cells in
non-draining brachial LNs, suggesting that our infection model
reflects a local immune response in draining LNs (Figure S1).We
further examined co-stimulatory marker expression on MHC-
II+ CD11c+ DCs in LD and HD-draining LNs at 24 h p.i. CD80
and in particular CD86 levels were significantly increased in
HD-draining LNs as compared to non-draining or LD-draining
LNs, in line with an inoculum-dependent local inflammatory
response (Figure S2). In sum, both LD and HD LCMV infection
triggered activation of transferred P14 and SMARTA T cells,
yet with distinct kinetics and magnitude of activation marker
expression and proliferation. Ag-specific T cells in LD-draining
LNs displayed a delayed upregulation of activation marker
expression with lower peak levels as compared to T cells of
HD-draining LNs.
Dynamic T Cell Behavior in Reactive LNs
During the First 72h of LD LCMV Infection
We set out to correlate the activation and proliferation dynamics
with dynamic properties of Ag-specific T cells during LD LCMV
infection. To benchmark T cell motility parameters in the absence
of inflammation, we transferred P14, SMARTA, and control
T cells into non-inflamed recipient mice and performed 2PM
of steady-state LNs. From image sequences, we determined
average track speed, meandering index (MI; actual migrated
distance divided by euclidian distance between start and end
point of track), arrest coefficient (percentage of track segments
with speeds below 4 µm/min) and percentage of “synapse-
like” motility. As surrogate readout for synapse-like motility, we
defined an average track speed of < 4 µm/min as threshold. This
value corresponds to previously published low speeds observed
during stable T cell—DC interactions in reactive LNs (7, 8). The
definition of a threshold speed to determine synapse-like motility
as surrogate readout for T cell interactions with APCs follows a
protocol described by Bousso et al. (16). It is important to keep in
mind that in our experimental system, we did not visualize APCs.
Therefore, synapse-like motility does not necessarily correlate
with actual interactions with APCs.
2PM image sequence analysis uncovered high interstitial
motility of P14, SMARTA, and control T cells with comparable
average speeds of 15–16 µm/min (Figures 2A,B). MI values
were also comparable (mean 0.60–0.66) and correlated with
low arrest coefficients and complete absence of synapse-
like behavior (Figures 2C,D and Video S1). Thus, all three
transferred cell populations displayed an active scanning
behavior in resting, non-inflamed LNs characteristic of naïve T
cells during homeostasis.
In LD LCMV-draining LNs at 24 p.i., all three cell populations
continued to migrate with high speeds, with SMARTA T
cells even displaying an increase in average cells speeds to
17.5 ± 9.7 µm/min (Figures 3A,B and Video S2). In contrast,
P14 and SMARTA T cells displayed a minor but significant
decrease in MI as compared to control T cells (Figure 3C).
In P14 T cells, this correlated with a moderately higher arrest
coefficient (Figure 3D) and low but detectable levels of synapse-
like behavior in P14 and SMARTA populations at 24 h post LD
LCMV infection (Figure 3E).
At 48 h post LD LCMV infection, 2PM imaging of reactive
LNs revealed a decrease in P14 and SMARTA T cell speeds to
7.6 ± 3.2 and 6.7 ± 4.6 µm/min, respectively. Of note, control
T cells also displayed a decrease in speeds (9.7 ± 4.1 µm/min),
which was less pronounced than that of Ag-specific T cells
(Figures 3F,G and Video S3). While MI values showed a non-
significant decrease in SMARTA T cells as compared to control
T cells (Figure 3H), decreased P14 and SMARTA speeds were
reflected in higher arrest coefficients (median 14, 25, and 43% for
control, P14, and SMARTA T cells, respectively) and synapse-like
arrest, in particular for SMARTA T cells (44%; Figures 3I,J).
At 72 h post LD LCMV infection, control, P14, and SMARTA
T cells began to recover cell speeds (11.4 ± 3.6, 8.9 ± 3.8 and 8.3
± 4.5 µm/min, respectively), with no significant changes in MI
values but increased arrest coefficient in Ag-specific T cells (0, 18,
and 25% for control, P14, and SMARTA T cells, respectively;
Figures 3K–N and Video S4). As a result, synapse-like motility
remained detectable in P14 and SMARTA T cells, albeit at lower
levels than at 48 h p.i. (Figure 3O).
In sum, our 2PM analysis detected minor alterations in
Ag-specific T cell motility parameters in the first 72 h post
LD LCMV infection. We did not observe widespread synapse-
like behavior under these conditions, indicating that a low
inoculum of a replicative agent does not necessarily lead to
general T cell arrest within the first 72 h p.i. In the time
windows analyzed, most Ag-specific T cells maintained robust
motility throughout the observation period, suggesting “kinapse-
like” transient interactions as dominant mode of T cell—DC
communication. Nonetheless, it is equally possible that synapse-
like behavior remains a prerequisite for full T cell activation
in this setting, with the low frequency of apparent synapse
formation reflecting the infrequent presence of APC.
Dynamic T Cell Behavior During the First
72h of HD LCMV Infection
We performed analogous experiments using 2PM of reactive LNs
after HD LCMV infection. At 24 h p.i., P14 and SMARTA T
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FIGURE 2 | T cell motility parameters in non-infected LNs. (A) Representative 2PM images of control (white), P14 (green), and SMARTA T cell tracks (blue) with HEV
(orange) at 96 h after adoptive T cell transfer. Arrowheads point the tracked cell: control (white), P14 (green), and SMARTA (blue). Scale bar, 20µm. (B–D)
Quantification of the 2PM motility parameters: Migration speed (B), meandering index (C), and arrest coefficient (D) of control (gray), P14 (green), and SMARTA T cells
(blue). Red lines depict median. Each dot represents a single track. Data are pooled from two independent experiments with a total of three mice. Statistical
significance in (B–D) was analyzed by unpaired Mann-Whitney test of control vs. P14 and SMARTA T cells, respectively.
cell speeds and MI values had strongly decreased as compared
to non-infected or LD LCMV-infected LNs (4.1 ± 2.6 and 4.8
± 2.5 µm/min for speeds and 0.29 ± 0.23 and 0.29 ± 0.26 for
MI, respectively; Figures 4A–C and Video S5). Control T cells
also displayed a significant reduction in their average speeds,
although less pronounced than in Ag-specific T cells (Figure 4B).
Reduced P14 and SMARTA motility was mirrored in high arrest
coefficients and a high percentage of synapse-like behavior (66
and 47%, respectively; Figures 4D,E). Thus, HD LCMV infection
precipitates extensive arrest of Ag-specific T cells in reactive LNs
within 24 h p.i.
At 48 h post HD LCMV infection, P14 and SMARTA
T cells continued to display a mostly stationary behavior
with low speeds (5.8 ± 3.5 and 6.7 ± 3.8 µm/min,
respectively), low MI, and high arrest coefficients (Figures 4F–I
and Video S6). This resulted in an elevated percentage of
synapse-like motility in P14 and SMARTA T cells (36 and 22%,
respectively), which was nonetheless lower than at 24 h p.i.
(Figure 4J). Similar to 24 h p.i., control T cells were moving
faster and more directional than Ag-specific T cells, albeit
with lower motility parameters as compared to uninfected
LNs (Figures 4G–I).
At 72 h post HD LCMV infection, reactive LNs had massively
expanded (not shown). In 2PM image sequences, we observed
continued low motility parameters in Ag-specific P14 and
SMARTA T cells, with P14 T cells occasionally found in clusters
(Figure 4K andVideo S7). This behavior correlated with low P14
and SMARTA T cell speeds (5.8 ± 4.3 and 5.1 ± 3.0 µm/min,
respectively), low MI values, increased arrest coefficients and
elevated percentages of synapse-like behavior (48 and 50%,
respectively; Figures 4L–O). At this time point, control T cells
also displayed significantly lower speeds (6.8± 3.4 µm/min) and
MI values (0.36 ± 0.26) as compared to 24 and 48 h post HD
LCMV infection. Concomitantly, we observed increased arrest
coefficients and synapse-like motility in these cells, although at
lesser extent than that of Ag-specific T cells (Figures 4N,O).
This behavior may reflect Ag-specific activation of a subset of
polyclonal T cells. Alternatively, since our relative imaging depth
as compared to the LN diameter was reduced in HD LCMV-
infected LNs owing to their massive expansion, the observed
control cells located in the outermost LN area, where T cells
speeds are generally lower (17). Taken together, our data show
that Ag-specific T cells undergo a rapid switch in their scanning
behavior early duringHDLCMV infections, with sustained arrest
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FIGURE 3 | T cell motility in reactive LNs during LD LCMV infection. (A) Representative 2PM images of control (white), P14 (green), and SMARTA T cell tracks (blue)
with HEV (orange) at 24 h p.i. Arrowheads point the tracked cell: control (white), P14 (green), and SMARTA (blue). Scale bar, 20µm. (B–E) Quantification of 2PM
motility parameters at 24 h p.i.: Migration speed (B), Meandering index (C), arrest coefficient (D), and percentage of synapse-like T cell motility (E) of control (gray),
P14 (green), and SMARTA T cells (blue). (F) Representative 2PM images of control, P14, and SMARTA T cells with HEV (orange) at 48 h p.i. as in (A). Arrowheads
(Continued)
Frontiers in Immunology | www.frontiersin.org 6 September 2019 | Volume 10 | Article 2086
Sivapatham et al. Infection-dependent T Cell Motility
FIGURE 3 | point the tracked cell and * indicate arrested T cells. Scale bar, 20µm. (G–J) Quantification of 2PM motility parameters at 48 h p.i.: Migration speed (G),
Meandering index (H), arrest coefficient (I), and percentage of synapse-like T cell motility (J) of control (gray), P14 (green), and SMARTA T cells (blue).
(K) Representative 2PM images of control, P14, and SMARTA T cells with HEV at 72 h p.i. as in (A). Arrowheads point the tracked cell and * depict arrested T cells.
Scale bar, 20µm. (L–O) Quantification of 2PM motility parameters at 72 h p.i.: Migration speed (L), Meandering index (M), arrest coefficient (N), and percentage of
synapse-like T cell motility (O) of control (gray), P14 (green), and SMARTA T cells (blue). Red lines depict median. Each dot represents a single track. Data are pooled
from three independent experiments with a total of four mice (24 h), four mice (48 h), and two mice (72 h). Statistical significance was analyzed by unpaired
Mann-Whitney test of control vs. P14 and SMARTA T cells, respectively. *p < 0.05; **p < 0.01; ***p < 0.001.
of T cell populations observed within the first 72 h p.i. inside
reactive LNs.
High Viral Inoculum Induces Immediate T
Cell Arrest Through Cognate pMHC Levels
in Reactive LNs
We explored the mechanisms responsible for early T cell arrest
under HD infection conditions. It is conceivable that in addition
to cognate pMHC, a highly inflammatory environment suffices
to trigger T cell arrest even when cognate pMHC levels are
low or moderate, as observed in control T cells at late time
points of HD infection. This may occur via increased activation
levels of APCs reflected by increased levels of co-stimulatory
molecules and cytokine secretion, recruitment of circulating T
cells, downregulation of promigratory factors, rapid activation
marker expression or changes in intrinsic T cell motility (18–
20). To explore this aspect in more detail, we transferred control,
P14 and SMARTA T cells into recipient mice. One day later,
we co-infected recipients with LD LCMV Clone 13 and HD
LCMVClone 13-A3. The latter virus contains a pointmutation in
the LCMV gp33-43 epitope preventing P14 T cell activation but
preserving the SMARTA-specific epitope (21, 22). In this setting,
the total viral inoculum corresponds to HD infection but cognate
pMHC levels for P14 T cells correspond to LD infection. At 24 h
p.i., we performed 2PM imaging of reactive LNs (Figures 5A,B
and Video S8). Similar to HD LCMV infection, SMARTA T
cells displayed strongly reduced speeds (6.1 ± 3.4 µm/min),
low MI values and increased arrest coefficients (Figures 5C–E).
This resulted in an increased synapse-like behavior as compared
to control cells, reminiscent of HD LCMV infections (33%)
(Figure 5F). In contrast, motility parameters of P14 T cells were
remarkably similar to LD LCMV infection only. Thus, P14 T
cells displayed only a minor decrease in cell speeds (12.4 ± 4.5
µm/min) and MI (0.58 ± 0.25) as compared to control T cells
(13.0± 4.2µm/min and 0.61± 0.24, respectively; Figures 5C,D).
As a result, the arrest coefficient remained comparably low,
with essentially no synapse-like motility pattern (Figures 5E,F).
This observation suggests that cognate pMHC levels are a
major determinant of early T cell arrest, even in a highly
inflamed environment.
DISCUSSION
The aim of this study was to correlate activation and dynamic
behavior of Ag-specific T cells in reactive LNs during the first 72 h
p.i. with low and high viral inoculum. Our data support following
conclusions: first, T cell deceleration occurs as a function of initial
viral load, similar to results obtained with transferred DCs pulsed
with varying peptide concentrations or potency (5–9). Second,
the innate immune system is capable to process abundant virus
material for presentation on MHC at levels sufficient to induce
T cell arrest within 1 day post infection. Under high initial viral
inoculum, cognate pMHC may be presented in high levels on
the surface of APC, and/or distributed on an increased number
of APCs. Third, even very low doses of initial virus inoculum
induce a noticeable alteration in Ag-specific T cell motility, which
precedes detectable surface expression of early activationmarkers
such as CD69 and CD25.
One concern with previous observations using ex vivo
peptide-pulsed DCs was that this approach created pMHC
levels not attainable during physiological viral infections, since
it bypasses Ag processing and can lead to uniform cognate
peptide presentation on all available MHC molecules. Our data
show that at least with the experimental system used here,
pMHC-dependent T cell arrest can be observed within 1 day
after viral infection. Our reductionist experimental system bears
several limitations: the inoculum used may not represent levels
of initial viral load under physiological conditions. In addition,
we neither determined the levels of cognate pMHC on individual
APCs nor their frequency. It remains therefore unknown
whether T cell arrest is a consequence of their interactions
with increased numbers of APCs presenting viral antigen and/or
whether individual APC present high levels of cognate pMHC.
Furthermore, the transfer of high numbers of Ag-specific T
cells required for 2PM experiments may impact viral infection
kinetics or competition for access to pMHC-presenting DCs. It
is therefore likely that the presence of supraphysiologic numbers
of P14 and SMARTA T cells will dominate over the endogenous
response, as reflected in low activation of endogenous T cells
shown in Figure 1. Starting 3–4 days after HD viral infection,
transferred effector T cells will conceivably contribute to efficient
virus elimination, thus altering the dynamic of a natural virus
infection. Effector T cell egress may take longer under LD
conditions, as cell proliferation in reactive LNs becomes apparent
only at 5 days p.i. (Figure 1). While we have not checked the
functionality of SMARTA and P14 effector T cells under LD
infection, systemic infection of as few as 2 × 102 pfu LCMV-WE
leads to robust effector T cell generation (23).
In the LD model used here, the percentage of CD69+ and
CD25+ Ag-specific T cells continues to increase up to 72 h p.i.,
while the MFI of both activation markers tends to peak at 48 h
p.i. Similarly, 2PM data showed that Ag-specific T cells speeds
recover by 72 h post LD infection as compared to 48 h p.i.,
while synapse-like behavior declined at this time point. Thus,
our data suggest that the dynamic behavior of Ag-specific T
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FIGURE 4 | T cell motility in reactive LNs during HD LCMV infection. (A) Representative 2PM images of control (white), P14 (green), and SMARTA T cell tracks (blue)
with HEV (orange) at 24 h p.i. Arrowheads point the tracked cell: control (white), P14 (green), and SMARTA (blue). Scale bar, 20µm. (B–E) Quantification of 2PM
motility parameters at 24 h p.i.: Migration speed (B), Meandering index (C), arrest coefficient (D), and percentage of synapse-like T cell motility (E) of control (gray),
P14 (green), and SMARTA T cells (blue). (F) Representative 2PM images of control, P14, and SMARTA T cells with HEV (orange) at 48 h p.i. as in (A). Arrowheads
point the tracked cell and * indicate arrested T cells. Scale bar, 20µm. (G–J) Quantification of 2PM motility parameters at 48 h p.i.: Migration speed (G), Meandering
(Continued)
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FIGURE 4 | index (H), arrest coefficient (I), and percentage of synapse-like T cell motility (J) of control (gray), P14 (green), and SMARTA T cells (blue).
(K) Representative 2PM images of control, P14, and SMARTA T cells with HEV at 72 h p.i. as in (A). Arrowheads point the tracked cell and * depict arrested T cells.
Scale bar, 20µm. (L–O) Quantification of 2PM motility parameters at 72 h p.i.: Migration speed (L), Meandering index (M), arrest coefficient (N), and percentage of
synapse-like T cell motility (O) of control (gray), P14 (green), and SMARTA T cells (blue). Red lines depict median. Each dot represents a single track. Data are pooled
from five independent experiments with four mice (24 h), six mice (48 h), and eight mice (72 h). Statistical significance was analyzed by unpaired Mann-Whitney test of
control vs. P14 and SMARTA T cells, respectively. *p < 0.05; **p < 0.01; ***p < 0.001.
FIGURE 5 | High viral inoculum induces immediate T cell arrest through high pMHC levels in reactive LNs. (A) Experimental layout. Fluorescently labeled control, P14,
and SMARTA T cells were analyzed by 2PM microscopy at 24 h post co-infection with HD LCMV Clone 13-A3 and LD Clone 13. (B) Representative 2PM images of
control (white), P14 (green), and SMARTA T cell tracks (blue) with HEV (orange). Arrowheads point the tracked cell and * indicates complete T cell arrest. Scale bar,
20µm. (C–F) Quantification of 2PM motility parameters: Migration speed (C), Meandering index (D), arrest coefficient (E), and percentage of synapse-like T cell
motility (F) of control (gray), P14 (green), and SMARTA T cells (blue). Red bars depict median. Each dot represents a single track. Data are pooled from four
independent experiments with a total of eight mice. Statistical significance was analyzed by unpaired Mann-Whitney test of control vs. P14 and SMARTA T cells,
respectively. **p < 0.01; ***p < 0.001.
cells is fundamentally distinct under LD and HD conditions
throughout the activation process, as suggested by studies using
distinct pMHC loading (4–8). Nonetheless, we cannot exclude
that priming dynamics may simply be shifted in the LD infection
model toward later time points, with long-term synapse-like
interactions occurring after 72 h p.i., the latest time point we
have examined.
During natural infections, the frequency and activation status
of antigen-specific T cells varies between pathogens and changes
with age, which likely impacts on the dynamic nature of T cell—
DC interactions (24). Nonetheless, our observations suggest that
the innate immune system is capable to react to very high antigen
doses for protein processing and MHC loading. Comparable
results were reported by other groups, who have observed rapid
T cell arrest (within < 24 h p.i.) in reactive LNs in other virus
models (25–27). Similarly, in sterile immunizationmodels, T cells
decelerate within <1 day (1, 9, 28–30). Taken together, pMHC
processing appears highly efficient over a wide range of initial
starting material.
Our data further support the concept that cognate pMHC
levels are not the only determinant for T cell motility, since
the overall level of inflammation had an impact on control T
cell migration. One potential factor responsible for the overall
decline in control T cell motility is thromboxane A2 released
by activated DCs, and which induces a meandering behavior
in naive T cells through Rho signaling (31, 32). Furthermore,
strong inflammation precipitates a loss of CCL21 and CCL19
expression, factors which maintain high basal motility in naive T
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cells (18, 19). Yet, within the 24 to 48 h p.i. time window, pMHC
levels appear as a decisive factor for T cell deceleration. This
became particularly evident in the mixed infection model, where
high cognate pMHC levels caused a loss of motility of antigen-
specific T cells (SMARTA) without affecting non-reactive T cells
(P14) despite a highly proinflammatory environment.
Here, we have not visualized DCs nor addressed the precise
phenotype of APCs. In pilot 2PM experiments using CD11c-
YFP recipients labeling macrophages and DCs (33), we found
that CD11c-YFP signal became low to non-detectable after
HD viral infections. This prevented us from directly assessing
whether T cells were in close proximity to APCs when they
showed low motility. In tissue sections, we could nonetheless
identify occasional CD11c-YFP+ cells in close association with
transferred P14 and SMARTA T cells (not shown). Furthermore,
flow cytometry analysis of endogenous MHC-II+ CD11c+ APCs
confirmed increased expression of CD80 and CD86 at 24 h
after HD infection (Figure S2), suggesting abundant availability
of activated DCs for long-term interactions with Ag-specific T
cells. Nonetheless, since we could not directly visualize DCs in
our system, we do not have direct evidence whether synapse-
like behavior of Ag-specific T cells directly correlates with APC
interactions. Yet, since control T cells remained consistently
more motile than antigen-specific CD4+ and CD8+ T cells under
all conditions tested, it is likely that Ag-specific T cell deceleration
is at least in part driven by pMHC-driven APC interactions. This
is further supported by the observation that P14 T cells remain
motile in LNs draining high levels of LCMV clone 13-A3, despite
the fact that costimulatory molecules on DCs increase under
these conditions. These data are in agreement with findings
by Bousso et al. on T cell deceleration after cognate peptide
administration into recipient mice (16). It is likely that viral
particles are directly transported via lymph from the site of
injection to draining LNs, where they are taken up by subcapsular
sinusmacrophages (34). Of note, we did not attempt to determine
kinetics of viral titers in reactive LNs over the first 72 h p.i. for
a correlation with dynamic T cell behavior. We speculated that
the relation between viral titer and viral material available for
MHC presentation may not necessarily match. Thus, under HD
conditions, viable and damaged viral particles may appear rapidly
in afferent lymphatics, whereas LD infection may require several
rounds of replication in the periphery before enough antigenic
material is transported actively or passively to draining LNs. At
later time points, migratory DCs may replace LN resident DCs
as most prominent APC. We did not specifically examine the
microenvironmental positioning of Ag-specific CD4+ vs. CD8+
T cells, which has been reported to differ depending on the
infection model used (25, 26). At 72 h after HD LCMV infection,
we occasionally detected P14 clusters with some interspersed
SMARTA T cells, indicative of interactions on a common DC
platform as has been proposed (25, 26).
Our results uncover that alterations in T cell motility
parameters precede detectable surface levels of early activation
markers, at least during LD infections. The mechanisms
underlying changes in dynamic T cell behavior before activation
marker expression are not fully understood to date. Its rapidity
suggests that it is independent of transcriptional regulation but
rather induced by biochemical signals. As example, short Ca-
fluxes correlate with transient arrest (35). An open question is
whether occasional synapse-like interactions observed in the LD
infection model remain a prerequisite for T cell proliferation, or
whether transient kinapse-like interactions suffice for activation
as has been reported (6). In LD infections, synapses might be
rare as a result of less frequent APC. It should be also noted
that we did not synchronize dwell times in our experiments by
blocking entry of circulating T cells, in order to avoid causing LN
hypocellularity during the 72 h observation period. It is therefore
likely that our image sequences contain T cells with distinct dwell
times, and therefore divergent Ag exposure, within the lymphoid
tissue. Nonetheless, at least in the HD LCMV infection model,
our flow cytometry analysis suggests most cells became rapidly
activated and followed a comparable kinetic throughout the time
points analyzed.
We did not address here whether kinapse- and synapse-like
behavior correlate with memory T cell formation. Firm T cell
arrest appears dispensable for effector T cell generation (6, 36).
Yet, absence of ICAM-1 on DCs prevents firm adhesion of CD8+
T cells and results in lack of memory formation (37). Similarly,
lack of the Cdc42 activator DOCK8 results in defective CD8+
T cell memory formation, correlating with defective adhesion to
DCs (38). Taken together, there is some evidence that persistent
T cell adhesion to DCs may influence memory T cell formation.
At the same time, memory precursor effector T cells are thought
to experience less inflammatory signals as compared to short-
lived effector T cells (39). Thus, the connection between memory
formation, DC interaction time, and signals interchanged during
prolonged firm adhesion remains incompletely understood.
Taken together, our data show that T cells respond
dynamically to varying viral inocula. The dynamic behavior of
responding T cells is not hardwired during microbial infections,
confirming studies employing peptide-pulsed DC transfer. We
consider kinapse- vs. synapse-like behavior of T cells as useful
probes to indirectly assess the relative abundance of cognate
pMHC levels inside lymphoid tissue during inflammation.
Changes in T cell motility parameters emerge as one of the
earliest signs of a burgeoning adaptive immune response and
reflect the adaptation of T cells to available Ag levels.
MATERIALS AND METHODS
Mice
Ai14 mice, which encode a floxed STOP codon followed by
tdTomato reporter gene under control of the ROSA26 promotor
(40), were crossed with ZP3-cre mice, which express cre in
oocytes (41), to generate “Ai-ZP” mice with ubiquitous red
fluorescence in all tissues. SMARTA mice carry a transgenic
MHC—II restricted TCR specific for the gp61−80 epitope of
the LCMV peptide (42). P14 mice express a transgenic MHC
class I restricted TCR specific for the gp33−41 epitope of the
LCMV glycoprotein (43). In some experiments, we used “P14-
GFP” mice that were derived from crossing the P14 line with
Tg 30Scha “Ubi-GFP” mice (44). Male and female 7–9 week-old
C57BL7/6mice were obtained from Janvier (Le Genest-Saint-Isle,
France). All animals were maintained in specific pathogen-free
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conditions at the Department of Biomedical Research, at
the Theodor Kocher Institute at the University of Bern and
University of Fribourg. All animal work has been approved
by the Cantonal Committees for Animal Experimentation and
conducted according to federal guidelines.
Reagents
The fluorescent dyes 5(6)-CFDA, SE (CFSE), (5-(and−6)-
(((4-chloromethyl) benzoyl) amino) tetramethylrhodamine)
(CMTMR, CellTracker orange) and Chloromethyl-coumarin
(CMAC, CellTracker blue) were purchased from ThermoFisher
(Basel, Switzerland) and the cell proliferation dye eFluor 670
was from eBioscience (San Diego, CA). mAb against PNAd
(MECA-79) was from nanotools (Freiburg, Germany) and
coupled to AlexaFluor-633 using a Protein Labeling Kit from
Molecular Probes (Basel, Switzerland). Fc receptor blocking mAb
(clone 2.4G2, 4.5 mg/mL) in FACS buffer (D-PBS supplemented
with 1% milk powder and 0.1% NaN3) was produced in-house.
T cells were fixed with 1% paraformaldehyde (PFA; Electron
Microscopy Sciences, Lucerne, Switzerland) diluted in D-
PBS. D-PBS supplemented with 10mM EDTA was used for
homogenizing LNs for flow cytometry experiments.
T Cell Purification/Labeling and Adoptive
Transfer
Polyclonal T cells were isolated from C57BL/6 or Ai-ZP mice.
LNs (popliteal, mandibular, inguinal, brachial, axillary) and
spleen were harvested and homogenized using a 70µm cell
strainer. CD8+ and CD4+ T cells from P14/P14-GFP and
SMARTA donors, respectively, were isolated using EasySep
negative selection kit (STEMCELL Technologies, Grenoble,
France). Polyclonal control T cells were isolated with mouse T
cell isolation kit (STEMCELL Technologies, Grenoble, France)
according to the manufacturer’s protocol. Purity of the isolated T
cells was tested using FACSCaliburTM (BD Biosciences) and was
typically> 90%. P14 CD8+ T cells were labeled with 5µMCFSE.
SMARTA CD4+ T cells were labeled with 2.5–5µM CMTMR
and polyclonal T cells from C57BL/6 mice were labeled with
20µM e670 (for flow cytometry) or 20µM CMAC (for 2PM
imaging) for 20min at 37◦C. For the proliferation assay, P14
CD8+ and SMARTA CD4+ T cells were labeled with 5µMCFSE
or 2µM Cell Tracker Violet (CTV). For 2PM intravital imaging,
2–3 × 106 cells of C57BL/6 or Ai-ZP control T cells, P14 CD8+
and SMARTA CD4+ T cells were transferred i.v. into sex- and
aged-matched C57BL/6 recipients 1 day prior to infection.
Viral Infection
One day after T cell transfer, LCMV Clone 13 was injected s. c.
either into the right (for 2PM) or right and left foot hock (for
flow cytometry) of C57BL/6 recipient mice at a low (1–10 × 102
plaque forming units, pfu) or high (7 × 105 pfu) inoculum in a
volume of 10 µL. The LCMV Clone 13-A3 strain was obtained
from the European Virus Archive (https://www.european-virus-
archive.com/) and carries a V->A mutation at position 35 of the
LCMV gp33-43 peptide, which prevents activation of P14 CD8+
cells (21, 22, 45). C57BL/6 recipient mice were co-infected with
HD LCMV Clone 13-A3 (7 × 105 pfu) and LD LCMV Clone 13
(1–10 × 102 pfu). For DC activation analysis by flow cytometry,
LCMVClone 13 was injected s. c. in the right (LD), and left (HD)
foot hock without previous T cell transfer.
2PM of the Popliteal LN
The popliteal LN of recipient mice was surgically exposed
for 2PM imaging at 24, 48, and 72 h p.i. as described (32).
Immediately prior to imaging, HEVs were labeled by i.v. injection
of AlexaFluor-633-conjugated MECA-79. 2PM imaging was
performed by using a Trimscope system equipped with an
Olympus BX50WI fluorescence microscope and an 20X (NA
0.95, Olympus) or 25X objective (NA 1.10, Nikon) and controlled
by the ImSpector software (LaVision Biotec, Bielefeld, Germany).
For detection of second harmonic generation of the collagen–
rich capsule, a MaiTai Ti: sapphire laser was turned to 840 nm
and to 780 nm for excitation of the fluorophores. To perform
four-dimensional analysis of cell behavior in situ, z-stacks of
11–16 images with 4µm spacing from areas 200–400 µm2 was
recorded every 20 s for 20–30min. Vivofollow software allowed a
continuous drift offset correction in real time using fine pattern
matching during 2PM imaging (46). Image sequences of z-stacks
were converted into volume-rendered four-dimensional videos
using Volocity software (Improvision, PerkinElmer, Cambridge,
UK). This software was used for semi-automated tracking of cell
motility with additional visual check to assure correct tracking.
Mean speeds andmeandering index, defined asmigrated distance
divided by euclidian distance between start and end point of
the track, were calculated from the (x, y, z) coordinates of
the cell centroids. The arrest coefficient was calculated as the
percentage per track a cell moved slower than 4 µm/min by
using a custom script for Matlab (MathWorks) (32). T cells
with the average track speeds below 4 µm/min were considered
as synapse-like interacting cells, while cell velocities above 4
µm/min were defined as non-interacting or kinapse-forming
T cells.
Flow Cytometry
At 24, 48, and 72 h p.i., virus-draining popliteal LNs and
non-draining brachial LNs were harvested from recipient mice
and homogenized using a CorningTM FalconTM tube with Cell
Strainer Snap Cap (5ml). 2–5 × 106 cells/well were plated on
96-well V-bottom plates and Fc receptors were blocked with
2.4G2 mAb for 20–30min at 4◦C. Cells were stained with
fluorochrome—conjugated mAbs CD8 (53–6.7), CD4 (GK1.5),
and CD69 (H1.2F3) from BioLegend (San Diego, CA) in 50–
100 µl FACS buffer for 20min at 4◦C. Alternatively, cells
were stained with biotinylated mAb against CD25 (PC61)
followed by secondary staining with fluorochrome-conjugated
streptavidin for 20min at 4◦C. For the proliferation assay at
72 and 120 h p.i., cells were stained for with fluorochrome-
conjugated mAbs against CD8 (53–6.7) and CD4 (GK1.5).
For DC activation analysis at 24 h p.i., cells were stained
with fluorochrome—conjugated against mAbs CD11c (N418),
MHC class II (M5/114.15.2), CD80 (16–10A1), and CD86
(GL-1) from BioLegend (San Diego, CA) in 30 µl FACS
buffer for 30min at 4◦C. Zombie RedTM (BioLegend) was used
as viability dye. After staining, the fixation was performed
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with 1% PFA for 20min at 4◦C. Samples were analyzed
using AttuneTM NxT Flow Cytometer and AttuneTM NxT
Software (ThermoFisher), FlowJoTM 10 software (Treestar) and
GraphPad Prism.
Statistical Analysis
Flow cytometry data were analyzed using unpaired Mann-
Whitney U-test or one-way ANOVA (Prism, GraphPad).
Significance levels: ∗ = p < 0.05; ∗∗ = p < 0.01; ∗∗∗ = p < 0.001.
P-values > 0.05 were considered non-significant.
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